Notice

The Conference on Transdisciplinary Research and Innovation Tokyo 2026] New Shape of Knowledge and Finance - Accelerating Social Implementation of Research / March 6, 2026 (Fri.) 13:30-14:20

2026.02.17

[Hyperdisciplinary Conference Tokyo 2026] New Shape of Knowledge and Finance - Accelerating Social Implementation of Research / Friday, March 6, 2026, 13:30-14:20.

At the Super-Differential Conference Tokyo 2026, hosted by LIVERNESS, a session entitled "New Shape of Knowledge and Finance: Accelerating Social Implementation of Research" (session partner: Sumitomo Mitsui Financial Group, Inc.

Hyperdifferential Conference Tokyo 2026 Details

Is the only way to do good research in academia is to continue to obtain government grants and corporate collaborations? Is the only way to implement social implementation to collect money from venture capitalists? Sumitomo Mitsui Financial Group is working to create a new trend in the "money" issue, which is inevitable when returning university knowledge to society. We will discuss a new connection between academia and society to foster research seeds, create startups, and accelerate the transformation of social structure.

We will have a program of discussions with researchers, ventures, and companies from a variety of perspectives, not limited to the themes of this session. For more information,Conference Websitefor more information.

New Shape of Knowledge and Finance
～Accelerate social implementation of research

Date: Friday, March 6, 2026
Place: Bellesalle Shinjuku Grand Conference Center
(Sumitomo Fudosan Shinjuku Grand Tower 5F, 8-17-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo)

speaker

Mr. Kunihito Takaichi
Director, Social Value Creation Department, Sumitomo Mitsui Financial Group, Inc.

After graduating from the University of Tokyo's Faculty of Economics in 1998, he joined Sumitomo Bank (currently Sumitomo Mitsui Banking Corporation). After being transferred to the Ministry of Economy, Trade and Industry (METI), he worked in the Corporate Planning Department from 2005, where he was assigned to the Americas Management Division (at the time) in 2014, where he was in charge of the U.S. foreign bank regulatory compliance as Group Manager. After that, he again worked in the Corporate Planning Department as Group Head and Deputy General Manager, and is currently the head of the project team for the formulation of the mid-term business plan.
Appointed as Director of Social Value Creation Promotion Department in October 2023 (current position).

Mr. Koji Murota
Deputy Director (Social Collaboration and Innovation), Kyoto University/ Director, Growth Strategy Headquarters

2020 Director of Industry-Government-Academia Collaboration Division, Kyoto University
2024 Director, Growth Strategy Division, Kyoto University To present

Keihanshin Startup Academia Coalition Program Representative
Advisory Board Member, Life Science Innovation Network Japan
Committee Member, BioCommunity Kansai

Qualifications
Small and Medium Enterprise Management Consultant
Certified International Investment Analyst (CIIA)
Certified by the Securities Analysts Association of Japan (CMA)

Mr. Eiichiro Mori
Associate Professor, Faculty of Medicine, Nara Medical University
Representative Director, MOLMIL Corporation

Spent his childhood in Chicago, Illinois, U.S.A. with co-founder Masataka Yamamoto (Director and COO). While a student at Nara Medical University, he engaged in basic research in cell biology. After completing a clinical internship at Nara Medical University Hospital, he went to the University of Texas, U.S.A., for further study. Through research into the pathophysiology of amyotrophic lateral sclerosis (ALS), a neurological intractable disease, he established MORMIL in June 2022 with scientific advisors Shunsuke Tomita (AIST) and Tomohide Saio (University of Tokushima), and Masataka Yamamoto and Kota Togami (CFO). The company received the KRP Award at HVC KYOTO 2023, the Grand Prize at Biotech Grand Prix 2023, and the Metagen Award, among others.

Moderator.

Shuichiro Takahashi
Representative Director, President and COO, Liverness, Inc.

D. (Life Sciences), Graduate School of Frontier Sciences, The University of Tokyo. Founding member of RIVANESS. He established the RIVANES research institute and built the foundation for research support and R&D projects. He has devised unique business models such as "RIVANESS Research Fund" and "L-RAD," a platform for unused research ideas, and has led many projects involving industry, academia, and education.

Registration for auditing is now open.

We look forward to welcoming many people from academia, local businesses, venture companies, large corporations, town factories, producers, local governments, junior high school, high school and technical college students, and others to the Hyperdifferent Fields Conference.

Click here to register to attend or participate.

Contact Us

For inquiries regarding this matter, please contact

Liverness Corporation (Nakajima, Seno)
TEL: 03-5227-4198
e-mail : [email protected]